Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • Page 24
brd4-inhibition-eases-sepsis-induced-kidney-injury
Posted inBiotechnology

BRD4 Inhibition Eases Sepsis-Induced Kidney Injury

April 21, 2026
In a compelling advancement in the battle against sepsis-associated acute kidney injury (AKI), researchers have illuminated a novel therapeutic target…
Read More
investigation-reveals-antibiotic-resistant-bacteria-among-gut-microbes-in-black-bears
Posted inBiotechnology

Investigation Reveals Antibiotic-Resistant Bacteria Among Gut Microbes in Black Bears

April 21, 2026
A groundbreaking study on the gut microbiome of American black bears (Ursus americanus) in eastern North Carolina has opened new…
Read More
genetic-study-links-alzheimer’s-biomarkers-to-brain-and-lipids
Posted inBiotechnology

Genetic Study Links Alzheimer’s Biomarkers to Brain and Lipids

April 21, 2026
In an unprecedented advancement in Alzheimer’s disease research, a comprehensive genome-wide association study (GWAS) meta-analysis has shed new light on…
Read More
new-study-identifies-key-cell-proteins-fueling-severe-viral-infections
Posted inBiotechnology

New Study Identifies Key Cell Proteins Fueling Severe Viral Infections

April 21, 2026
In groundbreaking research conducted at Umeå University, scientists have uncovered a new dimension in the ongoing battle against the spread…
Read More
enhancing-flavonol-and-flavanone-content-in-tomatoes-via-crispr/cas9-targeting-of-transcriptional-repressor-slmyb32
Posted inBiotechnology

Enhancing Flavonol and Flavanone Content in Tomatoes via CRISPR/Cas9 Targeting of Transcriptional Repressor SlMYB32

April 21, 2026
In groundbreaking research that promises to revolutionize the nutritional profile of tomatoes, scientists from Zhejiang University have unveiled the pivotal…
Read More
novartis-narrows-focus-for-anticoagulant-after-failure-to-best-eliquis-in-phase-3-trial
Posted inBiotechnology

Novartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial

April 21, 2026
A little over a year after reabsorbing its anticoagulant abelacimab, Novartis has now terminated two phase 3 trials for the…
Read More
diet-and-drinks-of-the-bronze-age-south-caucasus-uncovered
Posted inBiotechnology

Diet and Drinks of the Bronze Age South Caucasus Uncovered

April 21, 2026
The culinary heritage of the South Caucasus during the Bronze Age has long intrigued archaeologists and historians alike, offering glimpses…
Read More
postmenopausal-white-women-with-genetic-risk-regain-weight-at-twice-the-rate,-study-finds
Posted inBiotechnology

Postmenopausal White Women with Genetic Risk Regain Weight at Twice the Rate, Study Finds

April 21, 2026
In a groundbreaking study published in the journal Obesity, researchers at Penn State led by Harold Lee, an assistant professor…
Read More
navigating-with-excellence:-the-multi-faceted-service-lines-of-precision-logistics
Posted inGenetics

Navigating with Excellence: The Multi-Faceted Service Lines of Precision Logistics

April 21, 2026
The global pharmaceutical industry operates within one of the most demanding and high-stakes environments of our modern world. Unlike traditional…
Read More
racing-toward-first-fda-nod-for-autoimmune-car-t,-kyverna-bolsters-lead-with-full-sps-dataset
Posted inBiotechnology

Racing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS dataset

April 21, 2026
Kyverna Therapeutics has unveiled the full results from its registrational trial of miv-cel in stiff person syndrome (SPS), providing a…
Read More

Posts pagination

Previous page 1 … 22 23 24 25 26 … 554 Next page

Privacy Policy    Terms

Scroll to Top